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This study  was  designed  to evaluate  the  protective  activity  of  gallic  acid  (GA)  against  glyoxal  (GO)  an
advanced  glycation  intermediate-induced  renal  ﬁbrosis  in  experimental  rats.  Glyoxal  (i.p)  at  a dose  of
15 mg/Kg  body  weight/day  for 4 weeks  induces  renal  ﬁbrosis.  GA  was administered  orally  (100  mg/Kg
body  weight/day)  along  with  GO  for 4 weeks.  The  anti-ﬁbrotic  activity  of GA  was  analyzed  by measur-
ing  the  collagen  synthesis  and  deposition  in  renal  tissues  using  mRNA  expression  analysis  and  Masson
trichrome  staining  (MTS),  respectively.  The  nephroprotective  potential  of  GA  was  assessed  by  quantifying
the  markers  of  kidney  damage  such  as  serum  blood-urea-nitrogen  (BUN),  creatinine  (CR)  and  alkaline
phosphatase  (AP).  Moreover,  basement  membrane  damage  in renal  tissues  was  analysed  by  periodic  acid
Schiff’s (PAS)  staining.  GA  co-treatment  markedly  suppressed  the  GO-induced  elevation  in  mRNA  expres-
sion  of collagen  I  and  III,  MMP-2,  MMP-9  and  NOX  (p < 0.05,  respectively)  genes  as  compared  with  GO  alone
infused  rats.  In addition,  GA  co-treatment  signiﬁcantly  attenuated  the  GO  -induced  elevation  in  serum
markers  such  as BUN,  CR  and  AP  levels  (p < 0.05, respectively).  Furthermore,  GA  co-treatment  restored
back the  decreased  renal  super  oxide  dismutase  (SOD)  activity  (p <  0.05)  thereby  assuage  the reactive
oxygen  species  (ROS)  generation,  and maintained  the  normal  architecture  of glomerulus.  The  present
study  clearly  indicates  that GO -induces  renal  ﬁbrosis  by enhancing  GO/receptor  of  advanced  glycation
end  product  (RAGE)  induced  ROS generation  and  GA  effectively  counteracted  GO-induced  renal  ﬁbrosis
by  its  ROS  quenching  and  anti-glycation  activity.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).. Introduction
Glyoxal (GO) is a well known physiological -oxoaldehyde,
nd is involved in the formation of advanced glycation end prod-
cts (AGE) [24]. -oxoaldehydes are implicated as an important
ausative factor of renal dysfunction [51,66]. Studies have shown
hat the -oxoaldehydes are capable of interacting with membrane
roteins, nucleotides, and phospholipids [56]. Besides being a nat-
ral metabolite of glucose, GO can be formed by lipid peroxidation,
ucleic acid oxidation and degradation of glycated proteins [10,59].
O is also present in foods products, beverages and widely usedn industrial chemicals [1]. The reactive carbonyl group of GO can
eact with amino group of proteins to form covalent adducts known
s AGEs [45]. It has been reported that the circulatory levels of -
∗ Corresponding author.
E-mail addresses: jainuddin.y@gmail.com (M.J. Yousuf), vellaie@gmail.com,
ellaie@unom.ac.in (E. Vellaichamy).
ttp://dx.doi.org/10.1016/j.toxrep.2015.07.007
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).oxoaldehydes are increased in hyperglycemic patients due to an
imbalance in the intracellular glucose metabolism [36].
Irreversible forms of AGEs are capable of altering the structure
and functions of membrane proteins as well as contractile proteins
[47]. An increased circulatory and tissues levels of AGEs have been
attributed to the secondary complication of diabetes [39]. We  have
previously demonstrated that infusion of GO induces renal dam-
age and modulates the redox potential in experimental rats, most
likely via receptor for AGEs (RAGE) mediated pathway [53]. In vitro
studies have shown that, AGE-RAGE-ROS signaling contribute to
the release of proinﬂammatory cytokines and growth factors that
are implicated in the pathogenesis of diabetic complications [27].
Recently studies have been initiated to identify molecules
that are capable of suppressing AGEs formation and its sec-
ondary complication in diabetic patients [57]. Aminoguanidine
(AG) is a well-known synthetic inhibitor of AGEs formation, and it
was reported to confer protection against AGE-mediated diabetic
nephropathy [41]. However, AG exhibits deleterious side-effects
such as gastrointestinal disturbances and abnormalities in liver
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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unction besides its beneﬁcial counteractions against AGEs [57]. At
his juncture, natural products have generally been proven to be
elatively safe for human consumption, as compared to synthetic
ompounds. There, has been an increasing interest in the use of
atural plant compounds, as anti-glycating agents [14].
Experimental studies on natural polyphenols such as, narin-
enin and its glycosides, quercetin and epicatechin exhibit a
igniﬁcant anti-glycation property [65]. Gallic acid (GA) (3,4,5-
rihydroxybenzoic acid), a natural antioxidant, has been reported
o confers free radical scavenging activity [50], anti- inﬂammatory
23] anti-hyperglycemic properties [3]. Gallic acid was reported to
ontain three hydroxyl groups bonded to the aromatic ring in an
rtho position exhibits the strongest free radical, scavenging activ-
ty [49]. The ortho substitution of hydroxyl groups to the aromatic
ing is good for anti-oxidant and free radical scavenging activity of
henolic acids [6]. We  have previously reported that GA effectively
ounteracted AGE-induced cell proliferation and oxidative stress
n H9C2 (2-1) rat cardiomyocyte cells [52]. Hence, in the present
tudy, we made an attempt to study the beneﬁcial counter actions
f GA against GO, an intermediate metabolite of AGEs induced renal
brosis in experimental rats.
. Materials and methods
.1. Animals
Experimental protocol pertaining the use of adult male Wistar
ats weighing about 120–150 g used in this study and has been
pproved by the Institutional Animal Ethics Committee. Animals
ere housed in plastic cages and kept at 25 ◦C with 12:12 h light:
ark schedule. All animals were fed standard pellet diet (M/s. Hin-
ustan Lever Ltd., Mumbai) and water ad libitum.
.2. Drugs and chemicals
Glyoxal, Bradford’s reagent and GA was purchased from Sigma
ldrich (MO, USA). All the other chemicals used were of analytical
rade.
.3. Experimental design
Animals are divided into four groups of 6 animals each. Group
: Control group animals received a daily injection of saline dur-
ng experimental period. Group 2: Animals received intraperitoneal
njections of glyoxal (15 mg/kg BW/day) for 4 weeks (GO). Group
: Animals receive an intraperitoneal injection of GO (15 mg/kg
W/day) along with oral administration of Gallic acid (100 mg/Kg
W/day) (GO + GA). Group 4: Animals received GA alone orally
100 mg/Kg BW/day) during the experimental period.
able 1
T-PCR oligonucleotide gene-speciﬁc primers.
Gene Primer sequences 
Collagen-I Sense 5′-TGCTGCTTGCAG TAACGTCG-3′
Antisense 5′-TCAACACCATCTCTGCCTCG-3′
Collagen III Sense 5′- AAAGGTGAAACTGGTGAACGTGGC-3′
Antisense 5′- TCCATCTTGCAGCCTTGGTTAGGA- 
MMP-2 Sense 5′- CTATTC TGTCAGCACTTTGG- 3′
Antisense 5′-CAGACTTTGGTTCTCCAACTT-3′
MMP-9 Sense 5′- AGTTTGGTGTCGCGGAGCAC-3′
Antisense 5′- TACATGAGCGCTTCCGGCAC-3′
NOX Sense 5′- GGACCCCGATCCCAACTACGC-3′
Antisense 5′- GCGCTTCCGAGAACGCTGGT-3′
GAPDH Sense 5′-TCCACCACCCTGTTGCTGTAGC-3′
Antisense 5′-TGGAAAGCTGTGGCGTGATG-3′y Reports 2 (2015) 1246–1254 1247
2.4. Biochemical analysis
After the experimental period the blood sample was collected
and centrifuged at 1500 × g for 10 min  at 4 ◦C. The clear supernatant
was used for further serum biochemical investigations, Blood urea
nitrogen (BUN) [40], serum creatinine (CR) [58] and serum alka-
line phosphatase (AP) [62]. Kidney tissues were homogenized
in Tris–HCl buffer (100 mM,  pH 7.4) using Teﬂon homogenizer
and centrifuged at 12,000 × g for 30 min  at 4 ◦C. The supernatant
obtained was  used for further studies. Protein content of renal
tissue extract was assessed by standard Bradford’s method [7].
The total collagen content was quantiﬁed by modiﬁed protocols
of Bergman and Loxley [5]. Thiobarbituric acid reactive substance,
an index of lipid peroxidation (LPO) was  performed using proto-
cols of Ohkawa et al.  [37]. Superoxide dismutase (SOD) activity was
determined using the methods of Kakkar et al. [20].
2.5. Histological examinations
Kidney tissue was ﬁxed in 4% paraformaldehyde solution and
embedded in parafﬁn wax. The sections obtained from kidney tis-
sues were stained using hematoxylin and eosin (H&E) staining [29],
Periodic acid Schiffs (PAS) staining [55] and Masson’s trichrome
staining [29] to observe the histological changes.
2.6. PCR analysis
Total cellular RNA was  isolated by Trizol method based upon
the method developed by Chomczynski and Sacchi [11]. To remove
genomic DNA contamination, RNA samples were treated with
RNase-free DNase I at 37 ◦C for 30 min. The integrity of RNA was
visualized by distinct 28 S and 18 S bands in 1.5% agarose gel elec-
trophoresis. PCR was  performed using GeNei M-MuLV RT-PCR kit
along with the primers listed in Table 1.
2.7. Gel activity assays
The activity of MMPs  was  detected using gelatin zymography
[33]. MMPs  activity was visualized as clear distinct bands against
blue background and was  quantiﬁed by scanning densitometry. The
antioxidant gel activity of SOD was determined by recommended
protocols. Tissue extracts were separated in 10% native PAGE and
the gel was  stained in Riboﬂavin-NBT solution gives clear SOD
bands against the blue–purple background of the gel [67].
2.8. ImmunostainingThe tissue sections were dewaxed; rehydrated using series of
alcohol and were incubated for antigen retrieval in citrate buffer
(pH 6.0). Following antigen retrieval process, the sections were
incubated with Goat polyclonal IgG RAGE, Rabbit polyclonal IgG
Size (bp) An.Tm (◦C)
136 60.8
578 61.3
3′
309 53
754 57
298 59
401 58
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Table 2
Effects of glyoxal, an AGE intermediate on body weight, kidney weight and KW/BW
ratio in control and experimental group of rats.
Parameters Control GO GO + GA GA
Body Weight (gm) 135 ± 5.8 110 ± 7.1a,* 125 ± 5.31b,* 130 ± 6.3 NS
Kidney Weight (gm) 0.7 ± 0.01 0.9 ± 0.02a,* 0.79 ± 0.03b,* 0.6 ± 0.02 NS
KW/BW ratio 0.52 ± 0.02 0.81 ± 0.02a,* 0.63 ± 0.01b,* 0.46 ± 0.01 NS
Values in the table are expressed as mean ± SEM, n = 6. No signiﬁcant NS-Control Vs
GA.
a GO Vs. Control.
b GO + GA Vs. GO.
* p < 0.05.
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Table 3
Effects of glyoxal, an AGE intermediate on serum BUN, Creatinine and alkaline phos-
phatase in control and experimental group of rats.
Parameters Control GO GO + GA GA
BUN (mg/dL) 14 ± 0.2 20 ± 1.4a,* 16 ± 0.8b,* 13 ± 0.2 NS
Creatinine (mg/dL) 0.15 ± 0.01 0.25 ± 0.02a,* 0.2 ± 0.02b,* 0.13 ± 0.01 NS
Alkaline phosphatase (U/L) 187 ± 9.8 239 ± 21.1a,* 197 ± 11.9b,* 185 ± 8.2 NS
Values in the table are expressed as mean ± SEM, n = 6. No signiﬁcant NS-Control Vs
GA.
aGO Vs. Control.
bGO + GA Vs. GO.
*p < 0.05.
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iMP-2, MMP-9, and Mn-SOD (1:100 each) primary antibodies
iluted in 1% BSA in PBS for 2 h at room temperature. The sections
ere washed in PBS and incubated with its speciﬁc secondary HRP
onjugated antibody at a dilution 1:250 for 1 h at room tempera-
ure. The peroxidase activity was visualized by treating the slides
ith DAB and was counterstained using Meyer’s hematoxylin.
.9. Immunoblot
Proteins were separated using SDS-PAGE and transferred to
VDF membrane, the membrane was processed with Goat poly-
lonal IgG RAGE (1:1000), Rabbit polyclonal IgG MMP-2 (1:500),
MP-9 (1:500) primary antibodies followed by HRP-conjugated
ntibody (1:2500) and developed using DAB solution.
ig. 1. Kidney sections from the control and experimental group animals were stained 
a–d).  Panel (a) normal control; Panel (b) GO infused rats; Panel (c) GO + GA treated rats;
e–h).  Panel (e) normal control; Panel (f) GO infused rats shows increase blue staining re
ild  increase in the blue stain in the tubules. Panel (h) GA control rats. PAS staining (i–l) v
nfused rats; Panel (k) GO + GA group animals; Panel (l) GA control animals, renal section2.10. Reactive oxygen species
Kidney tissue samples were prepared for dichlorodihydroﬂu-
orescein (DCF) ﬂuorescence according to previously described
method [32]. Formation of dichlorodihydroﬂuorescein (DCF) was
measured using a ﬂuorometer with excitation and emission wave-
lengths of 488 nm and 525 nm respectively.
2.11. Statistical analysis
Statistical analysis was performed using GraphPad Software
(San Diego, CA). The results are presented as mean ± SEM. Statistical
differences between groups were determined by one-way analysis
of variance (ANOVA) with Students t test.
with H & E; Masson trichrome and Periodic Schiff’s stain (n = 6/group). H&E stain
 Panel (d) GA control animals. Masson’s trichrome to visualize collagen deposition
ﬂects interstitial ﬁbrosis, panel (g) gallic acid treated renal sections GO + GA shows
isualize basement membrane damage. Panel (i) normal control; Panel (j) GO alone
s were shown at 40X magniﬁcation. Scale bar- 50 m.
icology Reports 2 (2015) 1246–1254 1249
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Fig. 2. (A) Shows the total collagen content in the kidney tissue of experimental
animals. Increased in the collagen content in GO group animals compared with the
control group and there was a signiﬁcant decrease in the collagen levels of GO + GA
group animals as compared with the GO group. No signiﬁcant change was observed
in  the GA group compared with the control group animals. (B and C) represents an
increased mRNA expression of Collagen I and Collagen III in GO group animals and
there was a signiﬁcant decrease in the mRNA expression levels of GO + GA  group ani-M.J. Yousuf, E. Vellaichamy / Tox
. Results
.1. Physiological parameters
Table 2 depicts the KW/BW ratio, which is an indicative of hyper-
rophic growth was increased (36%) signiﬁcantly in GO infused rats
s compared with control. Whereas, animals co-treated with gallic
cid exhibits protection against GO- induced hypertrophy.
.2. Biochemical parameters
Table 3 shows the levels of Blood Urea Nitrogen, serum creati-
ine and serum alkaline phosphatase in control and experimental
roup of animals. Animals co-treated with gallic acid showed a
igniﬁcant decline (p < 0.05) in the levels of serum biochemical
arkers as compared with GO alone treated rats. Animals received
A alone did not show any signiﬁcant changes in the serum bio-
hemical parameters as compared with that of the control animals.
.3. Morphology
Fig. 1. depicts the renal sections from control and experimental
roup of animals. Degenerating glomerulus and tubular epithelial
ells were seen in GO treated animals indicated by arrows (panel b)
owever, animals co-treated with GA (panel c) showed a protection
gainst glomerular damage as compared with the animals treated
ith GO alone. No signiﬁcant change was observed in the gallic acid
lone treated animals (plate d).
Collagen content was assessed by Masson’s trichrome staining
as shown in Fig.1(f) depicts the collagen deposition in the kidney
issues of GO received animals. However, animals co-treated with
A (panel g) showed decrease in the collagen content in the renal
issue as compared with GO treated animals.
Periodic Acid Schiff’s staining of the kidney tissue shows the
hickening of the basement membrane was evidenced by an
ncrease in the PAS stain in the tubular basement membrane, and in
he glomerulus in GO group animals (panel j). However, a decrease
n the PAS stain was observed in the GO + GA group of animal
panel k) in the degenerating tubules. No signiﬁcant changes in the
lomerulus and tubules were observed in control and GA control
roup animals panel (i) and (l).
.4. Collagen content
Fig. 2(A) depicts total collagen deposition in the kidney tissues
f control and experimental group of animals. An increase in the
ollagen accumulation in the kidney tissues of GO group animals
p < 0.01) was observed as compared with control group animals.
n the other hand, a signiﬁcant decrease in the total collagen con-
ent was evidenced in the kidney tissues of GO + GA group animals
p < 0.05) as compared with GO treated animals. No signiﬁcant
hange was observed in the animals treated with GA alone.
Fig. 2(B) explains the mRNA expression proﬁle of collagen I and
ollagen III gene in the kidney tissues of control and experimental
roup of animals. It was evidenced that an increase in the expres-
ion of collagen I (p < 0.01) and collagen III (p < 0.05) gene in the
O group animals was observed as compared with control group
nimals. Animals co-treated with GA showed a marked reduction
n the expression proﬁle of collagen I and III genes. No signiﬁcant
hange was observed in GA alone treated animals.
.5. Metalloproteinase accumulationFig. 3(A) exhibits the gelatinase activity in the kidney tissues
f control and experimental group animals. MMP-2 and -9 activity
as observed to be increased in the GO treated animals (p < 0.001mals. GAPDH was used as internal control. Results were expressed as Mean ± SEM
(n  = 6/group). Signiﬁcance is indicated as *p < 0.05; **p < 0.01 and NS- non
signiﬁcant.
and p < 0.05). However, animals co-treated with GA  showed a sig-
niﬁcant reduction in the gelatinase activity in the renal tissue as
compared with GO treated animals. No signiﬁcant change was
observed in the animals treated with GA alone.
Fig. 3(B) depicts the mRNA expression proﬁle of MMP-2 and -9
genes in the kidney tissue of control and experimental group ani-
mals. GO treated animals showed increased mRNA expression of
MMP-2 and -9 (p < 0.01, respectively) as compared with control ani-
mals. Conversely, animals co-treated with GA showed a signiﬁcant
decrease in the expression levels of the MMP-2 and -9 (p < 0.05,
respectively) in the kidney tissue as compared with GO treated
animals.
3.6. NADPH oxidase and ROS levels
Fig. 3(C) depicts the mRNA expression levels of NOX  in the kid-
ney tissues of the experimental group of animals. GO group animals
showed an increase in the expression levels of NOX (p < 0.01) as
compared with control animals. Animals co-treated with GA exhib-
ited a signiﬁcant reversion in the levels of NOX as compared with
GO treated animals.
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Fig. 3. Zymogram analysis of MMP-2 and -9 activity showing activity of MMP-2 and MMP-9 in the tissue extracts. Gels were stained with 0.25% Coommassie brilliant blue and
destained until the clear lytic bands were visible. Results were expressed as Mean ± SEM (n = 6/group). Signiﬁcance is indicated as *p < 0.05; **p < 0.01; ***p < 0.01 and NS- non
signiﬁcant. (B) mRNA expression of MMP-2 and -9 in control and experimental group animals. GAPDH was used as internal control. Results were expressed as Mean ± SEM
(n  = 6/group). Signiﬁcance is indicated as *p < 0.05; **p < 0.01 and NS- non signiﬁcant. (C) mRNA expression levels of NOX-4 in control and experimental group animals. GAPDH
was  used as internal control. Results were expressed as Mean ± SEM (n = 6/group). Signiﬁcance is indicated as *p < 0.05; **p < 0.01 and NS- non signiﬁcant. (D) The ﬁgure shows
the  spectroﬂourimetric analysis of ROS generation in control, GO, GO + GA and GA treated tissue extract. Results were expressed as Mean ± SEM (n = 6/group). Signiﬁcance is
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Fig. 3(D) depicts the ROS generation in control and experimen-
al group animals. GO treated animals showed an increase in the
OS generation in the renal tissue extract (p < 0.001) as compared
ith control group animals. However, GA co-treated rats showed
 signiﬁcant reduction in the ROS generation as compared with GO
lone treated rats.
.7. Immunostaining
Fig. 4 shows MMP-2 and MMP-9, RAGE and Mn  SOD protein
xpression in the renal tissue sections of control and experimen-
al group of rats. An increased expression of MMP-2 and MMP-9 in
he glolmerulus (panel b and f) was observed in the animals treated
ith GO alone. However, there was comparatively decreased in the
evels of MMP-2 and MMP-9 in the glomerulus (panel c and g) of
he GO + GA group animals. The photograph of glomerulus from
he control and GA control group animals showed no signiﬁcant
hanges. RAGE serves as a gateway for AGEs to induce cellular dam-
ge [61] was found to be increased in the GO administered group
f animals Fig. 4 (Panel j). The expression of RAGE was  reduced
n the GA co-treatment group of animals (Panel k) which shows
hat GA may  possess anti-AGEs property in renal injury. No change
n the glomerulus was observed in the control and GA group ani-
als. The immune expression of antioxidant enzymes superoxide
ismutase was measured using immunostaining Fig. 4 shows the
etection of Mn-SOD activity in experimental group animals and it
as observed that there was a decrease in the expression of MnSODlevels in GO alone administered group (Panel n) as compared with
control group animals (Panel m)  and animals receives GO along
with GA reveals decreased levels of MnSOD in the kidney tissue
(Panel o) which explains that natural bioﬂavanoid GA might be an
alternate source in delaying renal injury caused by food derived
glycotoxins.
3.8. Immunoblotting
Fig. 5 depicts the protein expression of MMP-2, MMP-9 and
RAGE in control and experimental group animals. An increase in
the levels of MMP-2 (p < 0.01), MMP-9 (p < 0.05) and RAGE (p < 0.01)
was observed in the renal tissues of GO treated animals, on the
other hand animals receives GA along with GO showed a signiﬁcant
reversion of the MMP-2, MMP-9 and RAGE in the kidney tissues of
experimental group animals. Animals receive GA alone showed no
signiﬁcant change as compared with the control group.
3.9. Antioxidant status
The results from the oxidative stress markers and the levels of
antioxidant enzymes in the kidney tissue of experimental animals
are represented in Fig. 6. GO received animals induced an imbalance
in the redox status, with increased levels of thiobarbituric acid reac-
tive substances (TBARS) (p < 0.01) and declining activities of SOD
(p < 0.01) was  found as compared to the control animals; whereas,
animals received GA express a reversion in the LPO and SOD  levels
M.J. Yousuf, E. Vellaichamy / Toxicology Reports 2 (2015) 1246–1254 1251
Fig. 4. Immunostaining analysis of kidney sections from the control and experimental group animals (n = 6/group). Panel (a–d) shows MMP-2, Panel (e–h) shows MMP-9,
Panel  (i–l) shows RAGE, Panel (m–p) shows SOD expressions in the kidney sections of control and experimental group of rats respectively. An increased MMP-2 and -9
expression is evidenced in (panel b and f, respectively) in GO treated rat renal sections. An increased RAGE and decreased SOD expression is evidenced in (panel j and n,
respectively) in GO treated rat renal sections. GA treatment neutralizes GO induced MMPs  (panel c and g, respectively) RAGE (panel k) and SOD (panel n) expressions in the
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aenal  tissue sections. Kidney tissue sections were observed at 40X Magniﬁcation.
s compared with the GO group. Fig. 6(C) shows the detection of
n-SOD gel activity in renal tissue homogenate of the experimen-
al animals. SOD activity was signiﬁcantly decreased in GO infused
nimal kidney tissue (p < 0.01). However, animals receive GO along
ith GA has a remarkable increase in the levels of SOD as compared
ith that of the GO group (p < 0.05).
. Discussion
The results of the present study demonstrated that GO an inter-
ediate metabolite of AGEs induces renal ﬁbrosis and that the
atural antioxidant GA effectively attenuated the GO- induced renal
brosis probably by attenuating the GO-induced ROS generation in
he kidney tissues of experimental rats.
The kidneys are the vital organs of circulatory system that are
esponsible for maintaining the electrolyte balance in the blood and
emoving the toxic materials from the blood. In the present study,
lyoxal treated animals showed a loss of body weight (Table 2)
nd renal hypertrophy (36%). AGEs and its intermediate glyoxal areconsidered as uremic toxins. These reactive molecules reported to
accumulate in the tubular epithelial cells and mesangium of the kid-
neys, and induce glomerular damage [43,17,34]. It has been shown
previously that, morphological changes in the kidney may  reﬂect
the renal hypertrophy and chronic progressive nephropathy [16].
Hence, the observed loss of body weight and increase in the kidney
weight/body weight ratio in the glyoxal treated rats was probably
due to glyoxal-induced renal injury.
Serum creatinine, and to a lesser extent blood urea, detects renal
dysfunction in many circumstances [2]. Creatinine is found to be a
reliable marker in renal injury. The kidneys maintain the levels of
creatinine by clearing it out from the body and elevation in the
levels of serum creatinine shows malfunction of kidneys. Similarly
urea is also a metabolic byproduct which can build up in the plasma
during renal insult. The BUN-to-creatinine ratio generally provides
more information about kidney function [26]. In the present study,
GO-induced animals showed elevated levels of serum creatinine
and BUN (Table 3) (p < 0.05). In contrast, animals received GA along
with GO showed signiﬁcantly decreased (p < 0.05) levels of serum
renal markers as compared to the GO treated animals. In addition,
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Fig. 5. Immunoblotting analysis of MMP-2, MMP-9 and RAGE. -actin was used
as  internal control. Where, Lane C-control; Lane GO – Glyoxal (GO) alone infused
rats; Lane GO + GA - Gallic acid (GA) along with GO group animals; Lane GA - GA
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s indicated as *p < 0.05; **p < 0.01 and NS- non signiﬁcant.
lkaline phosphatase (ALP) was also elevated in the GO treated ani-
als while GA treatment reverted back the elevated levels to near
ormal. ALP is a hydrolyze enzyme that dephosphorylates various
olecules, most effectively operating in an alkaline environment.
athologic conditions are most commonly associated with eleva-
ions in ALP [13]. In the present study, the elevated levels of ALP
ight be due to the poor detoxiﬁcation of glyoxal leads to liver dis-
omfort and thereby results in the elevation in the ALP. Combined
ogether, these results clearly indicated the nephroprotective role
f GA against the GO induced changes in kidney.
Diabetic nephropathy (DN) is characterized by enlargement of
he glomerulus and tubules [54]. Previous studies have shown that,
GEs were found to be deposited in tubular epithelial cells and in
he glomerular mesangium of kidneys [60]. It has been suggested
hat AGEs and its intermediates such as GO have the ability to cause
ytotoxicity [46], altered cell morphology, [54,44] and ﬁnally loss of
ellular architecture in kidney tissues [53]. The renal tissue sections
rom the glyoxal treated animals showed an increase in glomeru-
ar damage and basement membrane thickening. It explains the
eason for the renal impairment in these rats. An increase in the
ccumulation of polysaccharides in the glomerulus which are indi-
ated by arrows (Fig. 1) eventually affects the ﬁltration capabilities
f glomerulus as evidenced by an increased in PAS staining [18]. The
allic acid co-treated animals have shown a decreased PAS staining
n the basement membrane, and thereby minimize the severity of
asement damage as compared with glyoxal received animals.
Matrix metalloproteinase (MMPs) are the family of endopepti-
ases involved in the collagen degradation. It has been shown that
egraded products of MMPs  are the catalyst for collagen synthesis
38,28]. Moreover, an increase in the expression of MMPs  activity
ltimately leads to ﬁbrosis; whereas suppression of MMPs activity
s eventually results in decreased accumulation of ECM proteins
n tissues [25]. Studies have shown that engagement of AGE-RAGE
nduces ROS generation, thereby accelerates matrix metallo-
roteinase activity in experimental animals [9]. In the present
tudy, an increased MMP-2 and MMP-9 expression was observed
n GO received animals suggested that GO-RAGE-mediated ROS
eneration might induce MMP-2 and -9 activation. Conversely, a
igniﬁcant decrease in the expression of MMP-2 and -9 (p < 0.05)
as observed in GO + GA treated group of animals. Thus, GA beingy Reports 2 (2015) 1246–1254
a potential antioxidant might have scavenged the ROS thereby
minimizing the production and accumulation of collagen in the
GO treated renal tissues.
Receptor for advanced glycation end products (RAGE) serves
as the surface receptor for the AGEs, and it is responsible for the
downstream signaling of various pathological events. [12]. It was
reported that blockade or down-regulation of RAGE downstream
signaling could be a therapeutic target for various diseases [64].
Studies have showed that RAGE was  minimally expressed dur-
ing normal physiological conditions [48]. Studies have shown that
interactions of AGE/RAGE stimulate ROS generation, which could
promote RAGE expression, which warns to a vicious cycle between
RAGE-downstream signaling pathways [48]. Result of the present
study has shown that GO treated animals exhibited an increased
expression of RAGE. However, animals co-treated with GA  showed
decreased expression of RAGE, suggesting that GA counteracts GO,
and thereby minimizing the GO-induced RAGE activation and fur-
ther downstream signaling thus exhibited that it may act as a
natural anti-glycation agent.
A subunit of NADPH oxidase (NOX) plays a key role in pro-
duction of superoxide (O2−) by transferring electrons across the
membrane from NAD(P)H to molecular oxygen [4]. Activation of
NOX results in mitochondrial dysfunction and impaired antioxi-
dant status and ultimately leads to oxidative stress [8]. Studies
have suggested that the activation of RAGE induces NADPH oxi-
dase and cellular ROS production in endothelial cells [63]. Our
studies support the hypothesis that AGE-RAGE interaction, play
a key role in amplifying NOX and induces ROS generation in
the renal tissue [35]. Interactions of GO and RAGE stimulate
the NADPH oxidase and cytosolic production of ROS within the
renal tissues and this is inhibited by the natural anti-oxidant
GA. Furthermore, our own  recent study demonstrated the effec-
tiveness of GA as an anti-glycating agent for AGE  mediated
macro vascular complications [53]. In the present study, natu-
ral dietary ﬂavonoid GA attenuates the expression of NOX in
the kidney tissues by demonstrating its capability in GO/RAGE
mediated NOX activation during micro vascular complications
(Fig. 3).
Interaction of AGE/RAGE mediated oxidative stress alters the
antioxidant status of the renal system in diabetic nephropathy [42],
and this would alter the activity of enzymatic defense mechanisms,
ultimately contributing to excess cellular ROS accumulation [22].
Studies have shown that decrease in the activity of super oxide
dismutase (SOD) leads to the accumulation of ROS generation and
thereby leads to the ampliﬁcation of lipid peroxidation (LPO) [21].
Previous studies by Huang et al., showed that ﬂavanoids has the
ability to suppress AGEs mediated oxidative stress via RAGE [19].
Recent studies showed that increased collagen synthesis and MMPs
activity are related to SOD status and ROS formation [15]. In the
present study we  observed that more toxic role of GO in the induc-
tion of oxidative species with depletion of antioxidant enzyme
(Fig. 6) and increase in the ROS levels (Fig. 3). Animals exhibited a
signiﬁcant (p < 0.01) increase in the level of lipid peroxides (LPO)
with declining activities (p < 0.01) of antioxidant enzymes such
as superoxide dismutase (Mn-SOD). On the other hand, animals
co-treated with GA reduces the LPO activity probably due to its
metal chelating properties [30] and thereby restoring the levels of
SOD to near normal levels might be due to the action of GA on
superoxide, hydroxyl and alkoxyl radical coupled to attenuate the
oxidative stress which eventually reduces cellular damage [31].
The experimental evidence suggests that AGEs formed from GO
and methylglyoxal contribute to collagen cross linking. In addition,regulates the antioxidant status, which collectively induced the
collagen synthesis and MMP  mediated ECM rearrangement and
subsequently ﬁbrosis. However, GA co-treatment along with GO
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Fig. 6. (A) indicates the released Malondialdehyde-an indicator of LPO is expressed as nmoles/mg protein. (B) Activity is expressed as 50% inhibition of epinephrine auto-
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nhibited these changes and improved the GO-induced ﬁbrotic
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